MedPath

utritional Evaluation and Optimisation in Neonates

Completed
Conditions
Preterm birth
Pregnancy and Childbirth
Registration Number
ISRCTN29665319
Lead Sponsor
Imperial College London (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
160
Inclusion Criteria

1. Preterm infants (either sex) born below 31 weeks of gestation (defined as less than or equal to 30 weeks and 6 days)
2. Written informed consent from parents

Exclusion Criteria

1. Major congenital or life threatening abnormalities
2. Inability to randomise in time to allow administration of trial parenteral nutrition (PN) within 24 hours of birth

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. For the amino acid intervention: non-adipose (lean) body mass measured by whole body MRI at term age equivalent<br>2. For the lipid intervention: hepatic magnetic resonance spectroscopy (MRS) to measure IHCL at term age equivalent
Secondary Outcome Measures
NameTimeMethod
1. Anthropometry (weight, length and head circumference) measured at term age equivalent<br>2. Brain MRI (brain volumes, white matter apparent diffusion co-efficient values, cerebral vessel tortuosity) measured at term age equivalent<br>3. Metabolic index of insulin resistance at term age equivalent (quantitative insulin-sensitivity check index [QUICKI]), calculated using fasting serum glucose and insulin<br><br>Added 07/12/2009:<br>4. Ratio of internal to subcutaneous adipose tissue at term age equivalent. <br>5. Serum triglyceride and serum bilirubin levels.<br><br>Added 11/05/2010: <br>6. Metabonomic profile <br>7. Incidence of death <br>8. Number of infants with incomplete follow-up<br><br>Added 24/03/2011:<br>9. Inflammatory markers and lipid profile
© Copyright 2025. All Rights Reserved by MedPath